After previously delaying its…
After previously delaying its decision date, the FDA has outright [...]
Regeneron’s allergen-blocking…
Regeneron’s allergen-blocking antibodies have reduced the symptoms of cat and [...]
Partners Daiichi Sankyo and Merck…
Partners Daiichi Sankyo and Merck & Co. are sharing phase [...]
The FDA’s ongoing effort to…
The FDA’s ongoing effort to establish a culture of “radical [...]
Braveheart Bio has waded into the…
Braveheart Bio has waded into the fight for a heart [...]
BioNTech’s HER2 antibody-drug…
BioNTech’s HER2 antibody-drug conjugate has beaten Roche’s Kadcyla in a [...]
The German pharma giant has found…
The German pharma giant has found a new pipeline leader [...]
The Food and Drug Administration…
The Food and Drug Administration today announced a plan to [...]
Nine months after closing a $450…
Nine months after closing a $450 million fundraise, Atlas Venture [...]
AC Immune is reducing its…
AC Immune is reducing its workforce by around 30% and [...]